Allergan reports 14.6% growth in net product sales for fourth quarter

Allergan reported $1.66 billion in total product net sales for the fourth quarter, which constitutes a 14.6% increase over total product net sales for the corresponding quarter in 2012, according to a press release. Total specialty pharmaceuticals net sales increased 14% compared with the fourth quarter of 2012, and total core medical devices net sales increased 17% over the prior year’s fourth-quarter numbers. Allergan also reported $1.04 in diluted earnings per share attributable to stockholders, which is less than the $1.05 in diluted earnings per share attributable to stockholders reported (Read more...)

Full Story →